Multiple System Atrophy, Parkinson Variant
7
1
3
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Automated Imaging Differentiation of Parkinsonism
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
AB-1005 Long-Term Follow-up Study
Transcutaneous Spinal Cord Stimulation Home Study
Abdominal Binders to Treat Orthostatic Hypotension in Parkinsonian Syndromes
Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy